Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 50 | 2022 | 904 | 8.540 |
Why?
|
| Mood Disorders | 15 | 2022 | 132 | 7.050 |
Why?
|
| Behavior Therapy | 15 | 2022 | 297 | 6.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 53 | 2022 | 1506 | 6.170 |
Why?
|
| Implosive Therapy | 19 | 2021 | 171 | 4.010 |
Why?
|
| Anxiety Disorders | 15 | 2020 | 426 | 3.620 |
Why?
|
| Depressive Disorder, Major | 10 | 2021 | 439 | 2.280 |
Why?
|
| Psychotherapy | 11 | 2022 | 253 | 1.850 |
Why?
|
| Psychotherapy, Group | 3 | 2020 | 55 | 1.690 |
Why?
|
| Telemedicine | 12 | 2017 | 700 | 1.600 |
Why?
|
| Phobic Disorders | 6 | 2014 | 227 | 1.580 |
Why?
|
| Treatment Outcome | 31 | 2022 | 7029 | 1.460 |
Why?
|
| Comorbidity | 24 | 2022 | 1426 | 1.450 |
Why?
|
| Depression | 16 | 2021 | 943 | 1.450 |
Why?
|
| Adult | 68 | 2020 | 21403 | 1.380 |
Why?
|
| Anxiety | 7 | 2019 | 422 | 1.300 |
Why?
|
| Psychiatric Status Rating Scales | 16 | 2013 | 782 | 1.270 |
Why?
|
| Male | 76 | 2020 | 37321 | 1.210 |
Why?
|
| Substance-Related Disorders | 10 | 2021 | 1242 | 1.190 |
Why?
|
| Patient Dropouts | 6 | 2018 | 98 | 1.180 |
Why?
|
| Female | 70 | 2022 | 38074 | 1.140 |
Why?
|
| Humans | 90 | 2022 | 68618 | 1.100 |
Why?
|
| Depressive Disorder | 9 | 2019 | 621 | 1.080 |
Why?
|
| Primary Health Care | 6 | 2019 | 703 | 1.050 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2018 | 88 | 1.020 |
Why?
|
| Phobia, Social | 2 | 2022 | 9 | 1.010 |
Why?
|
| Combat Disorders | 3 | 2016 | 102 | 1.000 |
Why?
|
| Connexins | 8 | 2012 | 35 | 1.000 |
Why?
|
| Somatoform Disorders | 2 | 2018 | 35 | 0.930 |
Why?
|
| Social Support | 6 | 2018 | 423 | 0.930 |
Why?
|
| Middle Aged | 45 | 2020 | 21147 | 0.910 |
Why?
|
| Patient Satisfaction | 5 | 2020 | 378 | 0.850 |
Why?
|
| Panic Disorder | 3 | 2011 | 121 | 0.830 |
Why?
|
| Mental Health Services | 4 | 2019 | 199 | 0.810 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2011 | 10 | 0.710 |
Why?
|
| Models, Psychological | 3 | 2010 | 180 | 0.680 |
Why?
|
| Cognition | 4 | 2015 | 513 | 0.670 |
Why?
|
| Afghan Campaign 2001- | 8 | 2016 | 78 | 0.670 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2019 | 91 | 0.670 |
Why?
|
| Avoidance Learning | 1 | 2019 | 58 | 0.660 |
Why?
|
| Trauma and Stressor Related Disorders | 1 | 2018 | 3 | 0.650 |
Why?
|
| Surveys and Questionnaires | 11 | 2016 | 2800 | 0.620 |
Why?
|
| Heart Conduction System | 7 | 2012 | 119 | 0.620 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 77 | 0.610 |
Why?
|
| Movement Disorders | 1 | 2018 | 58 | 0.610 |
Why?
|
| Young Adult | 21 | 2020 | 5717 | 0.610 |
Why?
|
| Checklist | 2 | 2016 | 76 | 0.610 |
Why?
|
| Military Personnel | 5 | 2017 | 221 | 0.580 |
Why?
|
| United States Department of Veterans Affairs | 8 | 2019 | 307 | 0.580 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2016 | 257 | 0.570 |
Why?
|
| Iraq War, 2003-2011 | 7 | 2016 | 85 | 0.570 |
Why?
|
| Psychometrics | 9 | 2016 | 514 | 0.560 |
Why?
|
| Social Behavior | 2 | 2010 | 164 | 0.550 |
Why?
|
| Personality Inventory | 4 | 2011 | 197 | 0.540 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 105 | 0.520 |
Why?
|
| Opioid-Related Disorders | 3 | 2015 | 298 | 0.510 |
Why?
|
| United States | 18 | 2021 | 7367 | 0.490 |
Why?
|
| Test Anxiety Scale | 1 | 2014 | 6 | 0.470 |
Why?
|
| Patient Compliance | 2 | 2014 | 402 | 0.470 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 1851 | 0.460 |
Why?
|
| Mental Disorders | 3 | 2015 | 659 | 0.450 |
Why?
|
| Interpersonal Relations | 3 | 2018 | 209 | 0.440 |
Why?
|
| Fear | 2 | 2012 | 239 | 0.440 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 767 | 0.430 |
Why?
|
| Prescription Drug Misuse | 1 | 2013 | 35 | 0.430 |
Why?
|
| Factor Analysis, Statistical | 7 | 2016 | 201 | 0.410 |
Why?
|
| Aged | 18 | 2019 | 14862 | 0.410 |
Why?
|
| Pain Measurement | 1 | 2013 | 328 | 0.400 |
Why?
|
| Heart Rate | 4 | 2015 | 568 | 0.400 |
Why?
|
| Suicidal Ideation | 4 | 2018 | 106 | 0.380 |
Why?
|
| Emotions | 4 | 2019 | 244 | 0.380 |
Why?
|
| Sleep | 1 | 2013 | 263 | 0.370 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.370 |
Why?
|
| Sinoatrial Node | 1 | 2010 | 14 | 0.350 |
Why?
|
| Personality Disorders | 1 | 2010 | 44 | 0.350 |
Why?
|
| Friends | 1 | 2010 | 33 | 0.350 |
Why?
|
| Personality | 1 | 2010 | 66 | 0.340 |
Why?
|
| Analysis of Variance | 5 | 2013 | 1040 | 0.340 |
Why?
|
| Psychophysiology | 1 | 2009 | 11 | 0.330 |
Why?
|
| Reflex, Startle | 1 | 2009 | 39 | 0.320 |
Why?
|
| Alcoholism | 4 | 2020 | 1109 | 0.320 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 2077 | 0.320 |
Why?
|
| Heart Block | 2 | 2005 | 49 | 0.300 |
Why?
|
| Craving | 4 | 2017 | 200 | 0.290 |
Why?
|
| Suicide | 2 | 2018 | 116 | 0.280 |
Why?
|
| Survivors | 2 | 2022 | 256 | 0.270 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 445 | 0.270 |
Why?
|
| Myocytes, Cardiac | 4 | 2012 | 442 | 0.260 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2016 | 17 | 0.260 |
Why?
|
| Prevalence | 5 | 2016 | 1619 | 0.250 |
Why?
|
| Clinical Protocols | 2 | 2019 | 172 | 0.250 |
Why?
|
| Cross-Sectional Studies | 5 | 2015 | 2279 | 0.230 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 5 | 2017 | 151 | 0.230 |
Why?
|
| Facial Expression | 1 | 2004 | 36 | 0.230 |
Why?
|
| Prescription Drugs | 2 | 2015 | 71 | 0.230 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 438 | 0.230 |
Why?
|
| Interview, Psychological | 3 | 2012 | 113 | 0.220 |
Why?
|
| Cyclonic Storms | 3 | 2013 | 59 | 0.210 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2019 | 468 | 0.210 |
Why?
|
| Pilot Projects | 3 | 2018 | 1342 | 0.200 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1140 | 0.200 |
Why?
|
| Models, Statistical | 2 | 2016 | 448 | 0.190 |
Why?
|
| Hospitals, Veterans | 2 | 2012 | 147 | 0.190 |
Why?
|
| Stress, Psychological | 3 | 2017 | 824 | 0.180 |
Why?
|
| Canada | 1 | 2020 | 267 | 0.170 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 1753 | 0.170 |
Why?
|
| Goals | 2 | 2020 | 65 | 0.170 |
Why?
|
| Adolescent | 7 | 2020 | 8912 | 0.170 |
Why?
|
| Internet | 2 | 2012 | 390 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 1033 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2018 | 652 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 94 | 0.150 |
Why?
|
| Perception | 1 | 2019 | 189 | 0.150 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2017 | 22 | 0.140 |
Why?
|
| Students | 2 | 2010 | 233 | 0.140 |
Why?
|
| Bundle of His | 3 | 2006 | 21 | 0.140 |
Why?
|
| Occupational Diseases | 1 | 2017 | 68 | 0.140 |
Why?
|
| Disabled Persons | 1 | 2017 | 94 | 0.140 |
Why?
|
| Electromyography | 2 | 2009 | 184 | 0.130 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 955 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1553 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 123 | 0.130 |
Why?
|
| Mice | 8 | 2012 | 8474 | 0.130 |
Why?
|
| Quality of Life | 2 | 2015 | 1515 | 0.130 |
Why?
|
| Sex Factors | 2 | 2012 | 1266 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 792 | 0.130 |
Why?
|
| Erectile Dysfunction | 1 | 2014 | 22 | 0.120 |
Why?
|
| Videoconferencing | 2 | 2011 | 43 | 0.120 |
Why?
|
| Electrocardiography | 4 | 2012 | 601 | 0.120 |
Why?
|
| Thinking | 1 | 2014 | 30 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2016 | 322 | 0.110 |
Why?
|
| Culture | 1 | 2014 | 75 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2016 | 296 | 0.110 |
Why?
|
| Chronic Pain | 1 | 2015 | 110 | 0.110 |
Why?
|
| Disasters | 2 | 2013 | 204 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2006 | 239 | 0.110 |
Why?
|
| Motor Activity | 2 | 2014 | 621 | 0.110 |
Why?
|
| Ventricular Remodeling | 3 | 2012 | 318 | 0.100 |
Why?
|
| Purkinje Fibers | 3 | 2012 | 20 | 0.100 |
Why?
|
| Risk | 1 | 2013 | 563 | 0.100 |
Why?
|
| Inpatients | 1 | 2014 | 208 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 247 | 0.100 |
Why?
|
| Age Distribution | 1 | 2012 | 320 | 0.100 |
Why?
|
| Southeastern United States | 1 | 2012 | 281 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2013 | 298 | 0.100 |
Why?
|
| Life Change Events | 1 | 2012 | 223 | 0.100 |
Why?
|
| Agoraphobia | 1 | 2011 | 59 | 0.100 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 30 | 0.100 |
Why?
|
| Pressure | 1 | 2012 | 252 | 0.100 |
Why?
|
| Patient Selection | 1 | 2015 | 592 | 0.100 |
Why?
|
| Home Care Services | 1 | 2011 | 84 | 0.090 |
Why?
|
| Animals | 9 | 2012 | 20881 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 317 | 0.090 |
Why?
|
| Length of Stay | 1 | 2014 | 780 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 517 | 0.090 |
Why?
|
| Connexin 30 | 1 | 2010 | 1 | 0.090 |
Why?
|
| Office Visits | 1 | 2010 | 83 | 0.090 |
Why?
|
| Self-Assessment | 1 | 2010 | 69 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1465 | 0.090 |
Why?
|
| Universities | 1 | 2010 | 191 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2010 | 122 | 0.080 |
Why?
|
| Rats, Wistar | 1 | 2010 | 371 | 0.080 |
Why?
|
| Hypochondriasis | 1 | 2008 | 3 | 0.080 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 57 | 0.080 |
Why?
|
| Pattern Recognition, Visual | 1 | 2009 | 69 | 0.080 |
Why?
|
| Self Concept | 1 | 2009 | 132 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2009 | 229 | 0.080 |
Why?
|
| Acoustic Stimulation | 1 | 2009 | 206 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 425 | 0.080 |
Why?
|
| Action Potentials | 2 | 2012 | 223 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 737 | 0.080 |
Why?
|
| Discriminant Analysis | 1 | 2007 | 36 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 4848 | 0.080 |
Why?
|
| Risk Factors | 5 | 2018 | 5731 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2006 | 200 | 0.070 |
Why?
|
| Models, Animal | 2 | 2006 | 252 | 0.070 |
Why?
|
| Affect | 1 | 2007 | 218 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 328 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 157 | 0.070 |
Why?
|
| Neural Conduction | 1 | 2005 | 24 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 2791 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2010 | 581 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2006 | 753 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2008 | 403 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2005 | 24 | 0.060 |
Why?
|
| Bundle-Branch Block | 1 | 2005 | 50 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 216 | 0.060 |
Why?
|
| Galvanic Skin Response | 2 | 2015 | 67 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 57 | 0.060 |
Why?
|
| Happiness | 1 | 2004 | 5 | 0.060 |
Why?
|
| Skin Physiological Phenomena | 1 | 2004 | 13 | 0.060 |
Why?
|
| Age Factors | 3 | 2017 | 1864 | 0.060 |
Why?
|
| Anger | 1 | 2004 | 47 | 0.060 |
Why?
|
| Self Report | 2 | 2017 | 371 | 0.060 |
Why?
|
| Saliva | 2 | 2015 | 142 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 204 | 0.060 |
Why?
|
| Myocardium | 1 | 2010 | 1204 | 0.060 |
Why?
|
| Hydrocortisone | 2 | 2015 | 291 | 0.050 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2004 | 141 | 0.050 |
Why?
|
| Speech | 1 | 2004 | 118 | 0.050 |
Why?
|
| Texas | 2 | 2013 | 92 | 0.050 |
Why?
|
| Gene Expression | 1 | 2004 | 770 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 5300 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 848 | 0.050 |
Why?
|
| Cues | 2 | 2015 | 654 | 0.050 |
Why?
|
| Health Surveys | 2 | 2013 | 489 | 0.040 |
Why?
|
| Heart | 1 | 2004 | 850 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2015 | 1451 | 0.040 |
Why?
|
| Psycho-Oncology | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cardiomegaly | 2 | 2012 | 213 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3259 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2019 | 291 | 0.040 |
Why?
|
| Marital Status | 1 | 2017 | 65 | 0.040 |
Why?
|
| Logistic Models | 2 | 2012 | 1420 | 0.030 |
Why?
|
| Veterans Health | 1 | 2017 | 62 | 0.030 |
Why?
|
| Electrophysiology | 2 | 2006 | 160 | 0.030 |
Why?
|
| Dehydroepiandrosterone | 1 | 2015 | 29 | 0.030 |
Why?
|
| Hawaii | 1 | 2015 | 24 | 0.030 |
Why?
|
| Unemployment | 1 | 2015 | 18 | 0.030 |
Why?
|
| Warfare | 1 | 2015 | 58 | 0.030 |
Why?
|
| Quetiapine Fumarate | 1 | 2014 | 20 | 0.030 |
Why?
|
| Dibenzothiazepines | 1 | 2014 | 15 | 0.030 |
Why?
|
| Aripiprazole | 1 | 2014 | 43 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 951 | 0.030 |
Why?
|
| Risperidone | 1 | 2014 | 48 | 0.030 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2014 | 9 | 0.030 |
Why?
|
| Criminal Law | 1 | 2014 | 30 | 0.030 |
Why?
|
| Exposure to Violence | 1 | 2014 | 19 | 0.030 |
Why?
|
| Behavior | 1 | 2014 | 59 | 0.030 |
Why?
|
| Quinolones | 1 | 2014 | 60 | 0.030 |
Why?
|
| Bereavement | 1 | 2014 | 39 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2014 | 130 | 0.030 |
Why?
|
| Piperazines | 1 | 2014 | 206 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1738 | 0.030 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2012 | 11 | 0.030 |
Why?
|
| Constriction | 1 | 2012 | 37 | 0.030 |
Why?
|
| Cell Size | 1 | 2012 | 76 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 2007 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 546 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2006 | 1692 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 248 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 282 | 0.020 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2012 | 57 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 209 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 392 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2012 | 239 | 0.020 |
Why?
|
| Data Collection | 1 | 2012 | 420 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 2093 | 0.020 |
Why?
|
| Vietnam | 1 | 2009 | 36 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2012 | 705 | 0.020 |
Why?
|
| Echocardiography | 1 | 2012 | 515 | 0.020 |
Why?
|
| South Carolina | 1 | 2015 | 2752 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 689 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2005 | 2550 | 0.020 |
Why?
|
| Rural Population | 1 | 2011 | 398 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 931 | 0.020 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2006 | 27 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 579 | 0.020 |
Why?
|
| Ventricular Function | 1 | 2006 | 93 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2006 | 133 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2006 | 29 | 0.020 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2005 | 6 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2005 | 24 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 742 | 0.020 |
Why?
|
| Heterozygote | 1 | 2005 | 174 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2006 | 153 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2003 | 87 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 615 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 371 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 181 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1174 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1034 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 738 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1293 | 0.010 |
Why?
|